{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:48:23Z","timestamp":1790246903176,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2002]]},"DOI":"10.1016\/s0959-8049(01)00366-5","type":"journal-article","created":{"date-parts":[[2002,10,14]],"date-time":"2002-10-14T11:12:48Z","timestamp":1034593968000},"page":"401-408","source":"Crossref","is-referenced-by-count":73,"title":["A Danish population-based analysis of 105 mantle cell lymphoma patients"],"prefix":"10.1016","volume":"38","author":[{"given":"N.S","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"de Nully Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0959-8049(01)00366-5_BIB1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data [see comments]","volume":"16","author":"Banks","year":"1992","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/S0959-8049(01)00366-5_BIB2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V78.2.259.bloodjournal782259","article-title":"Bcl-1, t(11;14), and mantle cell-derived lymphomas","volume":"78","author":"Raffeld","year":"1991","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/S0959-8049(01)00366-5_BIB3","first-page":"29","article-title":"Cytological and functional criteria for the classification of malignant lymphoma","volume":"31","author":"Lennert","year":"1975","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms","volume":"74","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.annonc.a058904","article-title":"European Lymphoma Task Force (ELTF)","volume":"5","author":"Zucca","year":"1994","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(01)00366-5_BIB6","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.1996.14.4.1269","article-title":"Mantle-cell lymphoma","volume":"14","author":"Velders","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(01)00366-5_BIB7","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/10428199709050890","article-title":"Mantle cell lymphomas","volume":"26","author":"Decaudin","year":"1997","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB9","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.1998.16.5.1922","article-title":"Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas","volume":"16","author":"Hiddemann","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0959-8049(01)00366-5_BIB10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0959-8049(97)10056-9","article-title":"Mantle cell lymphoma","volume":"34","author":"Oinonen","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB11","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB12","doi-asserted-by":"crossref","unstructured":"Anonymous; A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993, 329, 987\u2013994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s002770050545","article-title":"Management of mantle cell lymphoma","volume":"78","author":"Meusers","year":"1999","journal-title":"Ann. Hematol."},{"key":"10.1016\/S0959-8049(01)00366-5_BIB14","unstructured":"Fisher RI. Mantle cell lymphoma: prognostic factors and treatment results. In American Society of Hematology Educational Program Book. 1999, 325\u2013328."},{"key":"10.1016\/S0959-8049(01)00366-5_BIB15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series","volume":"92","author":"Groves","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0959-8049(01)00366-5_BIB16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/10428190009113383","article-title":"Non-Hodgkin's lymphoma subtypes over time in an unselected population of 646 patients","volume":"39","author":"Brincker","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/10428190009057643","article-title":"Is mantle cell lymphoma a sex-related disease?","volume":"37","author":"Decaudin","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB18","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB19","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1182\/blood.V90.10.4212","article-title":"Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease","volume":"90","author":"Andersen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB20","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","article-title":"p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis","volume":"87","author":"Greiner","year":"1996","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","article-title":"Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma","volume":"95","author":"Chiarle","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0959-8049(01)00366-5_BIB22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","article-title":"Patterns of survival in mantle cell lymphoma","volume":"6","author":"Zucca","year":"1995","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0959-8049(01)00366-5_BIB23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-2141.1997.4693273.x","article-title":"The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group","volume":"99","author":"Vandenberghe","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0959-8049(01)00366-5_BIB24","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.1997.15.4.1664","article-title":"Mantle cell lymphoma","volume":"15","author":"Majlis","year":"1997","journal-title":"J. Clin. Oncol."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804901003665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804901003665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T14:02:20Z","timestamp":1578405740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804901003665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002]]}},"alternative-id":["S0959804901003665"],"URL":"https:\/\/doi.org\/10.1016\/s0959-8049(01)00366-5","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}